U.S. Electronic Equipment and Components Stock News

NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Upstart (UPST) Secures $4 Billion Castlelake Loan Funding Deal

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...
NYSE:AEM
NYSE:AEMMetals and Mining

Is Agnico Eagle Mines (AEM) Cheap On Its Earnings Beat And Steady Outlook?

Agnico Eagle Mines (NYSE:AEM) just reported quarterly results that topped Wall Street earnings expectations while keeping its 2026 production outlook and dividend intact. For investors, that combination puts the latest stock move into clearer context. See our latest analysis for Agnico Eagle Mines. The latest quarterly beat and confirmation of guidance come after a share price that has fallen 23.3% over three months and 15.3% year to date, even as Agnico Eagle Mines has delivered a 3 year...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Atlassian (TEAM) Stock Still Looks Reasonable Despite Weak Cash Flow Questions

Atlassian stock has staged a sharp short term rebound but sits on a long stretch of weak returns, which contrasts with valuation checks that currently lean toward the shares looking cheap on several standard measures. Over the past 5 years, Atlassian has delivered a cumulative decline of 69.4%, which frames today’s share price near US$104 as a recovery off a much lower base rather than a long run success story. Expectations around Atlassian’s ability to convert its software revenue into...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

US Cybersecurity Stocks Facing New AI Rules What Investors Should Watch

US cybersecurity stocks sit at the crossroads of two powerful forces. On one side are rising concerns about AI being misused in hacks and cross border data theft. On the other are signs that regulators may tighten control of high risk AI tools after recent OpenAI related incidents. That mix can pressure some AI heavy giants while potentially giving select security focused players a relative edge. This article looks at 3 US cybersecurity stocks from the screener that appear closely exposed to...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

Should Alleged Undisclosed Discount Program and Excess Inventory Require Action From PROCEPT BioRobotics (PRCT) Investors?

In late July 2026, several law firms announced class action lawsuits against PROCEPT BioRobotics alleging that an undisclosed discount program led customers to buy handpiece units in volumes that materially exceeded procedure demand, inflating reported U.S. sales and creating more than 10,000 excess units of field inventory by the end of 2025. The complaints also claim PROCEPT’s guidance for 2025 lacked a reasonable factual basis because management allegedly knew pulled-forward sales and...
NYSE:CRCL
NYSE:CRCLSoftware

Circle (CRCL) Acquires 1,000 IBM Blockchain Patents For USDC Push

Circle Internet Group (NYSE:CRCL) has acquired nearly 1,000 blockchain patents from IBM. The deal is aimed at supporting the company’s USDC stablecoin and related financial tools. This move adds a large portfolio of crypto infrastructure intellectual property to Circle’s existing platform. Circle Internet Group is making this move at a time when the stock has come under pressure. NYSE:CRCL closed at $61.36, with the share price down 7.3% over the past week, 19.2% over the past month, and...
NasdaqGS:CGON
NasdaqGS:CGONBiotechs

What CG Oncology (CGON)'s Pivotal BOND-003 Phase 3 Data Means For Shareholders

CG Oncology recently reported that The Lancet Oncology published pivotal Phase 3 BOND-003 Cohort C data showing cretostimogene grenadenorepvec monotherapy achieved statistically significant complete responses with durable outcomes and a favorable safety profile in high-risk, BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ. The trial results suggest cretostimogene could fit smoothly into everyday urology practice because it avoids operating room time, anesthesia...
NYSE:HNI
NYSE:HNICommercial Services

How a High-Stakes Earnings Test for Revenue Expectations Will Impact HNI (HNI) Investors

Earlier this week, workplace furnishings maker HNI Corporation announced it would release quarterly earnings before market open on Thursday, with analysts expecting revenue to grow very sharply year on year from the same period last year. This earnings report carries extra weight because HNI has missed Wall Street revenue forecasts multiple times over the past two years, sharpening focus on whether it can now meet heightened expectations. We’ll now examine how expectations for a very large...
NYSE:XOM
NYSE:XOMOil and Gas

ExxonMobil Stock And 2 Oil Plays Tied To Iran Tension

Oil price swings and fresh conflict headlines in the Gulf are again front and center for markets. When missiles fly and supply routes face new questions, some stocks with close ties to energy pricing and global trade can see sharp moves, both positive and negative. This article focuses on three stocks from our Oil Volatility and Geopolitical Risk Stock Opportunities screener that are directly exposed to the latest U.S. and Iran flare up. You will see how each one might react to higher oil...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Stock Looks Cheap On Earnings But Weak On Execution

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the share price has moved further than the fundamentals suggest. The roughly 56.9% decline over the last 12 months means existing shareholders have taken a heavy hit, while potential new buyers are looking at a much lower entry point. The global restructuring plan that targets lower ongoing costs can support valuation over time. However, the...
NYSE:PATH
NYSE:PATHSoftware

UiPath (PATH) After Its Rebound, Does The Automation Story Still Leave Shares Cheap?

UiPath (PATH) continues to draw attention after recent trading left the stock at a last close of US$12.59. Investors are weighing its automation platform, international footprint and current share performance across different timeframes. See our latest analysis for UiPath. The recent 1 day share price return of 3.28% and 7 day share price return of 17.66% sit against a year to date share price decline of 20.72%, while the 1 year total shareholder return of 4.83% points to mixed but improving...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

CME Group (CME) Launches New Futures Products, Is The Stock A Bargain?

CME Group (CME) is drawing fresh attention after outlining new single stock futures, a FutureSports performance index partnership, recent Q2 earnings, and ongoing share buybacks, giving investors several developments to assess together. See our latest analysis for CME Group. The latest product launches and FutureSports partnership sit alongside a sharp 21.44% 1 month share price return and a 6.50% 7 day gain, even though the 1 year total shareholder return is slightly negative and the 3 year...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Coupang (CPNG) Joins The Fortune Global 500, Is The Stock Still 42% Undervalued?

Coupang (CPNG) has just entered the 2026 Fortune Global 500 list following years of investment in AI, robotics, and logistics infrastructure. This recognition puts the company’s global scale in sharper focus for investors. See our latest analysis for Coupang. Despite Coupang’s new place on the Fortune Global 500 and its upcoming August 4 earnings report, recent trading has been weak, with the share price down 13.77% over 30 days and 35.13% year to date, and the 1 year total shareholder return...
NYSE:OKE
NYSE:OKEOil and Gas

How Investors Are Reacting To ONEOK (OKE) Holding Its Dividend Steady Amid Perceived Valuation Gap

ONEOK recently maintained its quarterly dividend at US$1.07 per share (US$4.28 annualized) and now trades below some estimates of intrinsic value based on discounted cash flow and market multiples, ahead of its August 3 earnings report that is now in the past. This combination of steady cash returns and an apparent valuation gap versus estimated underlying cash flows is drawing fresh attention to ONEOK’s investment case. With the dividend affirmation highlighting capital return consistency,...
NasdaqCM:WSC
NasdaqCM:WSCConstruction

Is WillScot (WSC) Using Quick-Connect Canopies To Deepen Its Modular Ecosystem Advantage?

WillScot Holdings recently expanded its Clearspan portfolio by launching the Quick-Connect Canopy, a rapidly deployable, ISO-mounted fabric structure that creates covered workspace between compatible modular units, now available across select major U.S. markets. This product introduces a new way for customers to integrate modular buildings, storage containers and ground-level offices into weather-protected, workflow-optimized compounds for construction, industrial and event operations. Next,...
NasdaqCM:NN
NasdaqCM:NNSoftware

The Bull Case For NextNav (NN) Could Change Following Safran 5G PNT Interoperability Deal - Learn Why

In July 2026, NextNav Inc. announced an agreement with Safran Electronics & Defense to integrate and test interoperability between NextNav's terrestrial 5G Positioning, Navigation, and Timing network in Santa Clara County and Safran’s timing and navigation receiver for mission-critical uses such as drones, autonomous systems, critical infrastructure, and public safety. The collaboration highlights how 5G-powered 3D PNT signals could act as a complementary, more resilient layer alongside GPS...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin Coffee (OTCPK:LKNC.Y) Teams Up With Duolingo, Is A 29% Undervalued View Warranted?

Luckin Coffee (OTCPK:LKNC.Y) has moved into the spotlight after announcing a limited-time partnership with language app Duolingo. The collaboration ties summer beverages and merchandise to a back-to-school learning theme aimed at Gen Z customers. See our latest analysis for Luckin Coffee. Luckin Coffee's recent Duolingo partnership arrives after a strong 30-day share price return of 15.66%, although the share price is still down 8.22% year to date and the 1-year total shareholder return is...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Is Churchill Downs (CHDN) Undervalued Following Strong Second Quarter Results?

Churchill Downs (CHDN) is in focus after reporting second quarter and six month results on 29 July 2026, with sales, revenue and net income all higher than the figures recorded a year earlier. See our latest analysis for Churchill Downs. Despite the stronger second quarter, Churchill Downs' recent share price performance has been weak, with the stock down 20.92% year to date and the 1 year total shareholder return also lower at 19.28%. This suggests recent earnings have not yet shifted...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Medpace Holdings (MEDP) Is Up 10.8% After Boosting 2026 Outlook And Retiring 17% Of Shares - Has The Bull Case Changed?

Medpace Holdings, Inc. recently reported second-quarter 2026 results showing higher sales and net income than a year earlier, and it completed a US$1.57 billion share repurchase program that retired 17.25% of its shares. Soon after, the company raised its 2026 outlook, now projecting revenue between US$2.81 billion and US$2.89 billion and net income of US$494 million to US$514 million, signaling management’s confidence in current business trends. Next, we’ll examine how Medpace’s upgraded...
NYSE:SPNT
NYSE:SPNTInsurance

SiriusPoint (SPNT): Do Higher EPS And A New COO Redefine Its Profitability Playbook?

SiriusPoint Ltd. has reported past second-quarter 2026 results showing revenue of US$744.1 million versus US$748.2 million a year earlier, with net income rising to US$68.6 million and diluted earnings per share from continuing operations increasing to US$0.58 from US$0.50. Despite slightly lower revenue, SiriusPoint delivered higher profitability and has also strengthened its leadership bench with the appointment of a new Chief Operating Officer to drive technology and operational...
NYSE:AVB
NYSE:AVBResidential REITs

AvalonBay (AVB) Stock May Be 32% Undervalued Despite Raised Guidance

AvalonBay Communities has delivered a 15.1% total return over the past 3 years, yet the valuation picture is not straightforward. An intrinsic value estimate based on a Discounted Cash Flow (DCF) approach points to upside, while broader checks look more mixed. At the same time, market-based multiples suggest the stock is trading at about the right level, which puts extra focus on which lens investors choose to rely on. Over the last 3 years, AvalonBay Communities has returned 15.1%, which is...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Erie Indemnity (ERIE) Heads Into Q2 Earnings As Its Rebound Tests Valuation

Erie Indemnity (ERIE) is set to report Q2 2026 results after the market closes on July 30, 2026. This scheduled earnings release gives investors fresh information to reassess the insurance services stock. See our latest analysis for Erie Indemnity. Over the past week Erie Indemnity has seen a 7 day share price return of 17.87% and a 90 day share price return of 13.53%. However, the year to date share price return is down 10.53% and the 1 year total shareholder return has declined 28.17%. This...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox (CLX) Stock Trades At A Discount To Fair Value

Clorox stock is trading at about US$99.63 after a difficult few years for shareholders, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiples currently point to the shares looking inexpensive rather than stretched. Clorox has delivered a decline of roughly 29.1% over the past 5 years, which means the share price has lagged while the latest valuation checks now suggest more supportive pricing. Expectations that Clorox can continue to convert earnings into...
NYSE:DX
NYSE:DXMortgage REITs

Does Dynex Capital’s Earnings Volatility Reveal a Deeper Shift in DX’s Investment Playbook?

In July 2026, Dynex Capital reported second-quarter 2026 results showing net income of US$180.79 million, with basic and diluted earnings per share from continuing operations of US$0.80. An unusual aspect of these results is that first-half 2026 net income of US$100.43 million trails the second-quarter figure alone, highlighting quarterly volatility. We’ll now consider how this earnings volatility, particularly the stronger second quarter performance, may influence Dynex Capital’s broader...